Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypesGwen Lomberk, Raúl Urrutia|Nature Communications|2018Cited by 275
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma XenograftsGaspar J. Kitange, Jann N. Sarkaria, Raúl Urrutia et al.|Clinical Cancer Research|2012Cited by 151
Membrane-To-Nucleus Signaling Links Insulin-Like Growth Factor-1- and Stem Cell Factor-Activated PathwaysYujiro Hayashi, Tamás Ördög, David T. Asuzu et al.|PLoS ONE|2013Cited by 24
New Insights Into Pancreatic Cancer: Notes from a Virtual MeetingElisabeth Heßmann, Andreas Trumpp, Günter Schneider et al.|Gastroenterology|2021Cited by 5
Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer InitiationGareth Pollin, Gwen Lomberk|Epigenomes|2026Cited by 0